Serotonin-dopamine antagonist and Gilles de la Tourette's syndrome: an open pilot dose-titration study with risperidone.
van der Linden
C
C
Bruggeman
R
R
van Woerkom
T C
TC
D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D018492:Dopamine Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007555:Isoxazoles / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination / Q000187:drug effects; D010865:Pilot Projects; D010880:Piperidines / Q000008:administration & dosage* / Q000009:adverse effects; D018967:Risperidone; D012702:Serotonin Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D005879:Tourette Syndrome / Q000188:drug therapy*
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D007555:Isoxazoles; D010880:Piperidines; D012702:Serotonin Antagonists; D018967:Risperidone